Journal of the American Academy of Dermatology
Volume 62, Issue 2 , Pages 300-307 , February 2010

Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma

  • Rachel H. Gormley, BS

      Affiliations

    • Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
  • ,
  • Stephen D. Hess, MD, PhD

      Affiliations

    • Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
  • ,
  • Dipti Anand, MD

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
  • ,
  • Jacqueline Junkins-Hopkins, MD

      Affiliations

    • Department of Dermatology, The Johns Hopkins School of Medicine, Baltimore, Maryland
  • ,
  • Alain H. Rook, MD

      Affiliations

    • Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
  • ,
  • Ellen J. Kim, MD

      Affiliations

    • Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • Corresponding Author InformationReprint requests: Ellen J. Kim, MD, Hospital of the University of Pennsylvania, Perelman Center for Advanced Medicine, 1st Floor, Suite 3305, 3400 Civic Ctr Blvd, 3400 Spruce St, Philadelphia, PA 19104.

References 

  1. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768–3785
  2. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer. Blood. 1997;90:354–371
  3. Berti E, Tomasini D, Vermeer MH, Meijer CJ, Alessi E, Willemze R. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas: a distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol. 1999;155:483–492
  4. Agnarsson BA, Vonderheid EC, Kadin ME. Cutaneous T cell lymphoma with suppressor/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes. J Am Acad Dermatol. 1990;22:569–577
  5. Marzano AV, Ghislanzoni M, Gianelli U, Caputo R, Alessi E, Berti E. Fatal CD8+ epidermotropic cytotoxic primary cutaneous T-cell lymphoma with multiorgan involvement. Dermatology. 2005;211:281–285
  6. Kim YH, Willemze R, Pimpinelli N, Whittaker S, Olsen EA, Ranki A, et al. TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110:479–484
  7. Liu V, Cutler CS, Young AZ. Case records of the Massachusetts General Hospital, case 38-2007: a 44-year-old woman with generalized, painful, ulcerated skin lesions. N Engl J Med. 2007;357:2496–2505
  8. Santucci M, Pimpinelli N, Massi D, Kadin ME, Meijer CJ, Muller-Hermelink HK, et al. Cytotoxic/natural killer cell cutaneous lymphomas: report of EORTC cutaneous lymphoma task force workshop. Cancer. 2003;97:610–627
  9. Quarterman MJ, Lesher JL, Davis LS, Pantazis CG, Mullins S. Rapidly progressive CD8-positive cutaneous T-cell lymphoma with tongue involvement. Am J Dermatopathol. 1995;17:287–291
  10. Kim SK, Kim YC, Kang HY. Primary cutaneous aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma with atypical presentation. J Dermatol. 2006;33:632–634
  11. Massone C, Chott A, Metze D, Kerl K, Citarella L, Vale E, et al. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients. Am J Surg Pathol. 2004;28:719–735
  12. Urrutia S, Piris MA, Orradre JL, Martinez B, Cruz MA, Garcia-Almagro D. Cytotoxic/suppressor (CD8+, CD4) cutaneous T-cell lymphoma with aggressive course. Am J Dermatopathol. 1990;12:603–606
  13. Gelfand JM, Wasik MA, Vittorio C, Rook A, Junkins-Hopkins JM. Progressive epidermotropic CD8+/CD4 primary cutaneous CD30+ lymphoproliferative disorder in a patient with sarcoidosis. J Am Acad Dermatol. 2004;51:304–308
  14. Fika Z, Karkos PD, Badran K, Williams RE. Primary cutaneous aggressive epidermotropic CD8 positive cytotoxic T-cell lymphoma of the ear. J Laryngol Otol. 2007;121:503–505
  15. Kreuter A, Altmeyer P. Rapid onset of CD8+ aggressive T-cell lymphoma during bexarotene therapy in a patient with Sezary syndrome. J Am Acad Dermatol. 2005;53:1093–1095
  16. Introcaso CE, Kim EJ, Gardner J, Junkins-Hopkins JM, Vittorio CC, Rook AH. CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement. Arch Dermatol. 2008;144:1027–1029
  17. Csomor J, Bognar A, Benedek S, Sinko J, Fekete S, Krenacs L, et al. Rare provisional entity: primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma in a young woman. J Clin Pathol. 2008;61:770–772
  18. Bekkenk MW, Vermeer MH, Jansen PM, van Marion AM, Canninga-van Dijk MR, Kluin PM, et al. Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients. Blood. 2003;102:2213–2219
  19. Guitart J, Gerami P. Cutaneous cytotoxic T-cell lymphomas workshop. Presented at: Department of Dermatology, Northwestern University; June 13, 2008; Chicago, IL.
  20. Kikuchi A, Sakuraoka K, Kurihara S, Akiyama M, Shimizu H, Nishikawa T. CD8+ cutaneous anaplastic large-cell lymphoma: report of two cases with immunophenotyping, T-cell-receptor gene rearrangement and electron microscopic studies. Br J Dermatol. 1992;126:404–408
  21. Dummer R, Kamarashev J, Kempf W, Haffner AC, Hess-Schmid M, Burg G. Junctional CD8+ cutaneous lymphomas with nonaggressive clinical behavior: a CD8+ variant of mycosis fungoides?. Arch Dermatol. 2002;138:199–203
  22. Hivnor CM, Nguyen V, Rook AH, Junkins-Hopkins J, Gelfand JM, Nasta S, et al. CD8+ lymphoma in a patient with human immunodeficiency virus. Arch Dermatol. 2005;141:1321–1322
  23. Introcaso CE, Leber B, Greene K, Ubriani R, Rook AH, Kim EJ. Stem cell transplantation in advanced cutaneous T-cell lymphoma. J Am Acad Dermatol. 2008;58:645–649
  24. Wenzel J, Gutgemann I, Distelmaier M, Uerlich M, Mikus S, Bieber T, et al. The role of cytotoxic skin-homing CD8+ lymphocytes in cutaneous cytotoxic T-cell lymphoma and pityriasis lichenoides. J Am Acad Dermatol. 2005;53:422–427

 Funding sources: None.

 Conflicts of interest: None declared.

PII: S0190-9622(09)00249-7

doi: 10.1016/j.jaad.2009.02.035

Journal of the American Academy of Dermatology
Volume 62, Issue 2 , Pages 300-307 , February 2010